Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants — ACCELERATE  

Hepatitis C Clinical Trial

Official title: HCV-ACCELERATE Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants

Status Recruiting

Clinical Trial Summary

The overarching goal of this study is to develop a peer-based care coordination intervention for individuals with HCV who were recently released from correctional settings to promote linkage to and retention in HCV care. The investigators will assess the existing barriers and facilitators of HCV treatment initiation, HCV treatment completion, and sustained virologic response among individuals recently released from a U.S. jail or prisons in a randomized control trial. This study will assess the feasibility and process measures of a peer-enhanced HCV care coordination intervention among recently incarcerated individuals.

Clinical Trial Description

The proposed 2-year study will be a block, stratified, randomized controlled trial. Once consented and enrolled, participants will be randomly assigned to either the peer-enhanced intervention or referred to standard clinical care. The investigators will enroll 80 former inmates with chronic HCV who have been released from incarceration within the past 6 months. It is expected that enrollment will be completed by the fourth quarter of the first year. This will allow sufficient time for HCV treatment uptake, completion, determination of SVR, and assessment of reinfection. Individual participant follow-up will be 3 months on average for treatment, 3 months for SVR, and 3 months to assess for reinfection.

Elucidating the barriers and facilitators in the re-entry care cascade (as well as how they may be overcome) will be critical in designing sustainable models of care for HCV-infected former inmates. The investigators hypothesize that a peer-enhanced strategy will be more effective than standard referral in improving linkage to, and retention in, HCV care among individuals recently released from correctional settings. ;

Related Conditions & MeSH terms

• Hepatitis
• Hepatitis C

• NCT number: NCT04701437
• Study type: Interventional
• Source: Montefiore Medical Center
• Contact: Matthew Akiyama, MD
• Phone: 718-920-7175
• Email: makiyama@montefiore.org
• Status: Recruiting
• Phase: N/A
• Start date: December 17, 2021
• Completion date: March 31, 2024